RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

Search

Konecranes Oyj

Uždarymo kaina

73.8 1.86

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

72.65

Max

73.9

Pagrindiniai rodikliai

By Trading Economics

Pajamos

27M

100M

Pardavimai

69M

1.1B

P/E

Sektoriaus vid.

15.456

42.612

Pelnas, tenkantis vienai akcijai

1.27

Dividendų pajamingumas

2.2

Pelno marža

9.54

Darbuotojai

16,545

EBITDA

-600K

185M

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

2.20%

2.27%

Kitas uždarbis

2025-10-23

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

416M

5.9B

Ankstesnė atidarymo kaina

71.94

Ankstesnė uždarymo kaina

73.8

Konecranes Oyj Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-08-04 21:42; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

2025-08-04 21:21; UTC

Uždarbis
Pagrindinės rinkos jėgos

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

2025-08-04 20:45; UTC

Uždarbis

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

2025-08-04 19:15; UTC

Pagrindinės rinkos jėgos

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

2025-08-04 23:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-08-04 23:41; UTC

Rinkos pokalbiai

Nikkei May Rise on Fed Stimulus Hopes

2025-08-04 23:28; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-08-04 23:28; UTC

Rinkos pokalbiai

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

2025-08-04 21:30; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 21:21; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

2025-08-04 21:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 20:25; UTC

Rinkos pokalbiai

India Hits Back Over Russian Oil Purchases -- Market Talk

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss $938M >RIG

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss/Shr $1.06 >RIG

2025-08-04 20:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

2025-08-04 20:15; UTC

Uždarbis

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

2025-08-04 20:13; UTC

Uždarbis

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

2025-08-04 20:09; UTC

Uždarbis

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

2025-08-04 20:06; UTC

Uždarbis

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

2025-08-04 19:41; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Lower -- Market Talk

2025-08-04 19:28; UTC

Rinkos pokalbiai

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

2025-08-04 19:07; UTC

Rinkos pokalbiai

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

2025-08-04 18:27; UTC

Rinkos pokalbiai

Gold Climbs on Rate Cut Speculation -- Market Talk

Akcijų palyginimas

Kainos pokytis

Konecranes Oyj Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Konecranes Oyj

Konecranes Plc manufactures, sells, and services material handling solutions. It operates through three segments: Service, Industrial Equipment, and Port Solutions. The company offers workstation lifting system, overhead cranes, hazardous environment cranes and hoists, warehouse automation, and core of lifting, such as gears, motors, and controls; and provides crane advisory services. It also provides crane inspection and preventive maintenance, predictive maintenance and remote monitoring, corrective maintenance and retrofits, consultation services, modernization services; and parts, such as hook latch triggers and rope guide. In addition, the company offers container handling equipment, mobile harbor cranes, lift trucks, shipyard and bulk handling equipment, and spare parts; and provides operational software and services, port services. It serves automotive, container handling, general manufacturing, intermodal, metal production, mining, nuclear, paper and forest, petroleum and gas, power, shipyards, and waste to energy and biomass sectors. Konecranes Plc was founded in 1910 and is headquartered in Hyvinkää, Finland.